Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
Eli Lilly(LLY) stock is priced at $949.97, giving the company a market capitalization of 893.24B. It carries a P/E multiple of 35.09 and pays a dividend yield of 63.9%.
On 2026-05-08, Eli Lilly(LLY) stock traded between a low of $947.44 and a high of $979.95. Shares are currently priced at $949.97, which is +0.3% above the low and -3.1% below the high.
The Eli Lilly(LLY)'s current trading volume is 3.56M, compared to an average daily volume of 3.94M.
In the last year, Eli Lilly(LLY) shares hit a 52-week high of $1,133.95 and a 52-week low of $623.78.
In the last year, Eli Lilly(LLY) shares hit a 52-week high of $1,133.95 and a 52-week low of $623.78.
LLY News
Eli Lilly (NYSE:LLY) has issued $9b in bonds to help fund nearly $15b of acquisitions and a large manufacturing buildout. The company is committing about $4.5b...
Image source: The Motley Fool. Thursday, May 7, 2026 at 4:30 p.m. ET CALL PARTICIPANTS Chief Executive Officer — Sean Duffy President — Wei-Li Shao Chief Fina...
Key Points Eli Lilly's deep weight-management pipeline should allow it to remain the top player. The company could also make significant clinical progress els...
Analyst ratings
85%
of 33 ratingsMore LLY News
This week's dividend activity included increased payouts from Diamondback Energy (FANG) and PepsiCo (PEP) as well as declarations from companies such as Eli Lil...
Technology Eli Lilly's Retatrutide Is So Hot, The Unlaunched Weight-Loss Drug Is Already Getting Knocked Off Licensing Eli Lilly's new weight-loss drug is creat...
Guggenheim analyst Seamus Fernandez raised the firm’s price target on Eli Lilly (LLY) to $1,235 from $1,183 and keeps a Buy rating on the shares. The firm updat...
New insider activity at Eli Lilly & Co ( (LLY) ) has taken place on May 7, 2026. Unlock hedge fund-level data and powerful investing tools for smarter, sharper...
...
Retatrutide Black Market: Why Consumers Will Do Anything To Get Eli Lilly's New GLP 4:47 AM ET Eli Lilly's next-generation weight-loss drug, Retatrutide, could...
Key Points Investors have placed a high valuation on Eli Lilly because they believe GLP-1 drugs represent a massive opportunity. Eli Lilly is growing quickly...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.